Literature DB >> 25193297

Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.

Prabhakar R Polepally1, Krzysztof Huben2, Eyal Vardy3, Vincent Setola3, Philip D Mosier4, Bryan L Roth3, Jordan K Zjawiony5.   

Abstract

The neoclerodane diterpenoid salvinorin A is a major secondary metabolite isolated from the psychoactive plant Salvia divinorum. Salvinorin A has been shown to have high affinity and selectivity for the κ-opioid receptor (KOR). To study the ligand-receptor interactions that occur between salvinorin A and the KOR, a new series of salvinorin A derivatives bearing potentially reactive Michael acceptor functional groups at C-2 was synthesized and used to probe the salvinorin A binding site. The κ-, δ-, and μ-opioid receptor (KOR, DOR and MOR, respectively) binding affinities and KOR efficacies were measured for the new compounds. Although none showed wash-resistant irreversible binding, most of them showed high affinity for the KOR, and some exhibited dual affinity to KOR and MOR. Molecular modeling techniques based on the recently-determined crystal structure of the KOR combined with results from mutagenesis studies, competitive binding, functional assays and structure-activity relationships, and previous salvinorin A-KOR interaction models were used to identify putative interaction modes of the new compounds with the KOR and MOR.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Kappa, delta, and mu opioid receptors; Michael acceptor-type ligands; Molecular modeling; Salvinorin A and B

Mesh:

Substances:

Year:  2014        PMID: 25193297      PMCID: PMC4162805          DOI: 10.1016/j.ejmech.2014.07.077

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  26 in total

Review 1.  Synthesis of neoclerodane diterpenes and their pharmacological effects.

Authors:  Kimberly M Lovell; Katherine M Prevatt-Smith; Anthony Lozama; Thomas E Prisinzano
Journal:  Top Curr Chem       Date:  2011

2.  An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of Michael acceptors for drug discovery?

Authors:  Cristina Avonto; Orazio Taglialatela-Scafati; Federica Pollastro; Alberto Minassi; Vincenzo Di Marzo; Luciano De Petrocellis; Giovanni Appendino
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-10       Impact factor: 15.336

3.  Chemotype-selective modes of action of κ-opioid receptor agonists.

Authors:  Eyal Vardy; Philip D Mosier; Kevin J Frankowski; Huixian Wu; Vsevolod Katritch; Richard B Westkaemper; Jeffrey Aubé; Raymond C Stevens; Bryan L Roth
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

Review 4.  Neoclerodanes as atypical opioid receptor ligands.

Authors:  Thomas E Prisinzano
Journal:  J Med Chem       Date:  2013-04-18       Impact factor: 7.446

Review 5.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

Review 6.  Diversity and modularity of G protein-coupled receptor structures.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

7.  Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids.

Authors:  Jakub Fichna; Kevin Lewellyn; Feng Yan; Bryan L Roth; Jordan K Zjawiony
Journal:  Bioorg Med Chem Lett       Date:  2010-11-11       Impact factor: 2.823

8.  Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.

Authors:  Anthony Lozama; Christopher W Cunningham; Michael J Caspers; Justin T Douglas; Christina M Dersch; Richard B Rothman; Thomas E Prisinzano
Journal:  J Nat Prod       Date:  2011-02-21       Impact factor: 4.050

9.  Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.

Authors:  Prabhakar R Polepally; Kate White; Eyal Vardy; Bryan L Roth; Daneel Ferreira; Jordan K Zjawiony
Journal:  Bioorg Med Chem Lett       Date:  2013-04-04       Impact factor: 2.823

10.  Structure of the human κ-opioid receptor in complex with JDTic.

Authors:  Huixian Wu; Daniel Wacker; Mauro Mileni; Vsevolod Katritch; Gye Won Han; Eyal Vardy; Wei Liu; Aaron A Thompson; Xi-Ping Huang; F Ivy Carroll; S Wayne Mascarella; Richard B Westkaemper; Philip D Mosier; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

View more
  8 in total

1.  Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice.

Authors:  M Salaga; P R Polepally; M Zielinska; M Marynowski; A Fabisiak; N Murawska; K Sobczak; M Sacharczuk; J C Do Rego; B L Roth; J K Zjawiony; J Fichna
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

Review 2.  A review of salvinorin analogs and their kappa-opioid receptor activity.

Authors:  Jeremy J Roach; Ryan A Shenvi
Journal:  Bioorg Med Chem Lett       Date:  2018-03-12       Impact factor: 2.823

3.  Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.

Authors:  A F Marmolejo-Valencia; K Martínez-Mayorga
Journal:  J Comput Aided Mol Des       Date:  2017-03-31       Impact factor: 3.686

Review 4.  Opioid receptors: Structural and mechanistic insights into pharmacology and signaling.

Authors:  Yi Shang; Marta Filizola
Journal:  Eur J Pharmacol       Date:  2015-05-14       Impact factor: 4.432

5.  Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ-Opioid Receptor.

Authors:  Rachel S Crowley; Andrew P Riley; Amy F Alder; Richard J Anderson; Dan Luo; Sophia Kaska; Pamela Maynez; Bronwyn M Kivell; Thomas E Prisinzano
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

6.  Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.

Authors:  Andrew P Riley; Chad E Groer; David Young; Amy W Ewald; Bronwyn M Kivell; Thomas E Prisinzano
Journal:  J Med Chem       Date:  2014-12-09       Impact factor: 7.446

Review 7.  Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.

Authors:  Soumen Chakraborty; Susruta Majumdar
Journal:  Biochemistry       Date:  2020-09-22       Impact factor: 3.162

8.  Critical interactions between opioid and cannabinoid receptors during tolerance and physical dependence development to opioids in the murine gastrointestinal tract: proof of concept.

Authors:  Agata Szymaszkiewicz; Mikołaj Świerczyński; Marcin Talar; Prabhakar Reddy Polepally; Jordan K Zjawiony; Jakub Fichna; Marta Zielińska
Journal:  Pharmacol Rep       Date:  2021-06-16       Impact factor: 3.024

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.